Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Inv. presentation
Consulting agrmnt
SYNERGY PHARMACEUTICALS, INC. (SGYP) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/02/2019 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Changes in Control of Registrant, Departure...
Docs: "Notice of Effective Date filed in the United States Bankruptcy Court for the Southern District of New York"
04/29/2019 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Regulation FD Disclosure, Other Events, Fin...
Docs: "Confirmation Order of the United States Bankruptcy Court for the Southern District of New York"
04/12/2019 GN FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
04/02/2019 8-K Bankruptcy or Receivership, Financial Statements and Exhibits
Docs: "Debtors' Motion for Entry of an Order (i) Approving Settlement and (ii) Finding that the Proposed Modifications to the Proposed Plan do not Require Further Solicitation",
"Fourth Amended Joint Plan Of Reorganization of Synergy Pharmaceuticals Inc. and its Debtor Affiliate"
03/29/2019 GN Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
03/21/2019 GN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
03/21/2019 GN INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. (SGYP) and Lead Deadline: April 12, 2019
03/14/2019 GN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
03/14/2019 8-K Bankruptcy or Receivership, Financial Statements and Exhibits
Docs: "Third Amended Disclosure Statement for the Third Amended Joint Plan of Reorganization of Synergy Pharmaceuticals Inc. and Its Debtor Affiliate",
"Third Amended Joint Plan of Reorganization of Synergy Pharmaceuticals Inc. and Its Debtor Affiliate"
03/08/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
03/07/2019 GN Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP
03/06/2019 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Sale Order, entered March 1, 2019",
"Synergy Pharmaceuticals Announces Completion of Sale to Bausch Health"
03/01/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health"
02/28/2019 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
02/26/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets"
02/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2019 GN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Synergy Pharmaceuticals Inc. (SGYP)
02/11/2019 GN SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it filed a securities class action lawsuit in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc.
02/11/2019 SC 13G/A VANGUARD GROUP INC reports a 1.3% stake in Synergy Pharmaceuticals Inc
02/04/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2019 SC 13G/A BlackRock Inc. reports a 4.9% stake in SYNERGY PHARMACEUTICALS INC
01/10/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Asset Purchase Agreement by and among, Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health Ireland Limited"
01/02/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12/18/2018 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12/13/2018 8-K Acquisition/merger/asset purchase announced
Docs: "Asset Purchase Agreement by and among, Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health Ireland Limited, (Schedules and Exhibits have been omitted from this exhibit pursuant to Item 601(b)(2) of Regulation S-K and are not filed herewith. The registrant hereby agrees to furnish a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.)",
"Term Sheet, by and between Synergy Pharmaceuticals Inc. and CRG Servicing, LLC",
"Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets"
12/06/2018 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "Amendment to Limited Forbearance Agreement, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and the lenders party thereto"
11/26/2018 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "Limited Forbearance Agreement, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and the lenders party thereto"
11/19/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment and Waiver No. 6, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and the lenders party thereto"
11/15/2018 CT ORDER Form CT ORDER - Confidential treatment order:
11/14/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "AMENDMENT AND WAIVER NO. 5"
11/09/2018 10-Q Quarterly Report for the period ended September 30, 2018
11/06/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Waiver No. 4, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and the lenders party thereto"
11/01/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Synergy Pharmaceuticals Names Dr. Melvin K. Spigelman Chairman"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy